Cargando…

Reduction in initiations of HIV treatment in South Africa during the COVID pandemic

BACKGROUND: In response to the global pandemic of COVID-19, countries around the world began imposing stay-at-home orders, restrictions on transport, and closures of businesses in early 2020. South Africa implemented a strict lockdown in March 2020 before its first COVID-19 wave started, gradually l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benade, Mariet, Long, Lawrence, Rosen, Sydney, Meyer-Rath, Gesine, Tucker, Jeanne-Marie, Miot, Jacqui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970413/ https://www.ncbi.nlm.nih.gov/pubmed/35361209 http://dx.doi.org/10.1186/s12913-022-07714-y

Ejemplares similares

Reduction in initiations of drug-sensitive tuberculosis treatment in South Africa during the COVID-19 pandemic: Analysis of retrospective, facility-level data
por: Benade, Mariet, et al.
Publicado: (2022)

Do differentiated service delivery models for HIV treatment in sub-Saharan Africa save money? Synthesis of evidence from field studies conducted in sub-Saharan Africa in 2017-2019
por: Rosen, Sydney, et al.
Publicado: (2022)

Prior exposure to antiretroviral therapy among adult patients presenting for HIV treatment initiation or reinitiation in sub-Saharan Africa: a systematic review
por: Benade, Mariet, et al.
Publicado: (2023)

Fast-track treatment initiation counselling in South Africa: A cost-outcomes analysis
por: Larson, Bruce A., et al.
Publicado: (2021)

Effect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: An empirical modeling study
por: Bor, Jacob, et al.
Publicado: (2017)

Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa
por: Schnippel, Kathryn, et al.
Publicado: (2012)

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa
por: Onoya, Dorina, et al.
Publicado: (2018)

Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment Case
por: Meyer-Rath, Gesine, et al.
Publicado: (2017)

Getting resources to those who need them: the evidence we need to budget for underserved populations in sub‐Saharan Africa
por: Long, Lawrence C, et al.
Publicado: (2021)

Understanding the costs and the cost structure of a community-based HIV and gender-based violence (GBV) prevention program: the Woza Asibonisane Community Responses Program in South Africa
por: Larson, Bruce, et al.
Publicado: (2020)

Cost and outcomes of routine HIV care and treatment: public and private service delivery models covering low-income earners in South Africa
por: Long, L. C., et al.
Publicado: (2023)

The per-patient costs of HIV services in South Africa: Systematic review and application in the South African HIV Investment Case
por: Meyer-Rath, Gesine, et al.
Publicado: (2019)

Primary healthcare seeking behaviour of low-income patients across the public and private health sectors in South Africa
por: Govender, Kerensa, et al.
Publicado: (2021)

Attrition through Multiple Stages of Pre-Treatment and ART HIV Care in South Africa
por: Fox, Matthew P., et al.
Publicado: (2014)

Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa
por: Evans, Denise, et al.
Publicado: (2017)

Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa
por: Miot, Jacqui, et al.
Publicado: (2021)

The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa
por: Long, Lawrence C., et al.
Publicado: (2016)

Citizenship status and engagement in HIV care: an observational cohort study to assess the association between reporting a national ID number and retention in public-sector HIV care in Johannesburg, South Africa
por: Shearer, Kate, et al.
Publicado: (2017)

Optimal HIV testing strategies for South Africa: a model-based evaluation of population-level impact and cost-effectiveness
por: Johnson, Leigh F., et al.
Publicado: (2019)

Economic evaluation of a cluster randomized, non-inferiority trial of differentiated service delivery models of HIV treatment in Zimbabwe
por: Benade, Mariet, et al.
Publicado: (2023)

Prospects for HIV control in South Africa: a model-based analysis
por: Johnson, Leigh F., et al.
Publicado: (2016)

Health systems performance for hypertension control using a cascade of care approach in South Africa, 2011–2017
por: Benade, Mariet, et al.
Publicado: (2023)

Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?
por: Chiu, Calvin, et al.
Publicado: (2017)

The net cost of incorporating resistance testing into HIV/AIDS treatment in South Africa: a Markov model with primary data
por: Rosen, Sydney, et al.
Publicado: (2011)

Changing the South African national antiretroviral therapy guidelines: The role of cost modelling
por: Meyer-Rath, Gesine, et al.
Publicado: (2017)

Differentiated Service Delivery Models for HIV Treatment in Malawi, South Africa, and Zambia: A Landscape Analysis
por: Huber, Amy, et al.
Publicado: (2021)

Will differentiated care for stable HIV patients reduce healthcare systems costs?
por: Larson, Bruce A, et al.
Publicado: (2020)

The cost‐effectiveness of multi‐purpose HIV and pregnancy prevention technologies in South Africa
por: Quaife, Matthew, et al.
Publicado: (2018)

Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa
por: Jo, Youngji, et al.
Publicado: (2021)

Secondary distribution of HIV self-test kits by HIV index and antenatal care clients: implementation and costing results from the STAR Initiative in South Africa
por: Zishiri, Vincent, et al.
Publicado: (2023)

Inpatient Care Costs of COVID-19 in South Africa’s Public Healthcare System
por: Edoka, Ijeoma, et al.
Publicado: (2021)

Economic Outcomes of Patients Receiving Antiretroviral Therapy for HIV/AIDS in South Africa Are Sustained through Three Years on Treatment
por: Rosen, Sydney, et al.
Publicado: (2010)

The costs of interventions for type 2 diabetes mellitus, hypertension and cardiovascular disease in South Africa – a systematic literature review
por: Masuku, Sithabiso D., et al.
Publicado: (2022)

Volunteering, health and the homeless – the cost of establishing a student-run primary healthcare clinic serving the inner-city homeless in South Africa
por: Johnston, Deanne, et al.
Publicado: (2020)

Same-Day CD4 Testing to Improve Uptake of HIV Care and Treatment in South Africa: Point-of-Care Is Not Enough
por: Larson, Bruce A., et al.
Publicado: (2013)

Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa
por: van Rensburg, Craig, et al.
Publicado: (2019)

Resource Utilization and Costs of Care prior to ART Initiation for Pediatric Patients in Zambia
por: Iyer, Hari S., et al.
Publicado: (2014)

Role of data from cost and other economic analyses in healthcare decision-making for HIV, TB and sexual/reproductive health programmes in South Africa
por: Murphy, Joshua P, et al.
Publicado: (2021)

Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices
por: Terris-Prestholt, Fern, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qdrjardc53p0v6raq4kcodsdif